Sun Pharma eyes acquisitions in US, Europe and emerging markets

With a market share of 8.1% as per market research firm AIOCD-AWACS in September 2021, Sun Pharma has the highest share in the domestic pharmaceutical market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mCIXp7
via IFTTT